Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | MAPT | P10636 | 2/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 4/20 | 0.49 |
| ▸ | MLYCD | O95822 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | EGFR | P00533 | 1/20 | 0.44 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | KDM5A | P29375 | 2/20 | 0.43 |
| ▸ | KDM5C | P41229 | 2/20 | 0.43 |
| ▸ | KDM5B | Q9UGL1 | 2/20 | 0.43 |
| ▸ | KDM6B | O15054 | 1/20 | 0.43 |
| ▸ | TET3 | O43151 | 1/20 | 0.43 |
| ▸ | KDM4A | O75164 | 1/20 | 0.43 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.43 |
| ▸ | ASPH | Q12797 | 1/20 | 0.43 |
| ▸ | KDM4D | Q6B0I6 | 1/20 | 0.43 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.43 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3857943 | 0.91 | ALDH1A1 (0.57) | ALDH1A1MAPTL3MBTL1HPGDMLYCD | |
| SCHEMBL3854386 | 0.91 | KDM5B (0.57) | ALDH1A1MAPTL3MBTL1TP53KDM4E | |
| SCHEMBL3807628 | 0.89 | ALDH1A1 (0.49) | ALDH1A1MAPTL3MBTL1HPGDMLYCD | |
| SCHEMBL5808527 | 0.87 | ALDH1A1 (0.69) | ALDH1A1MAPTL3MBTL1HPGDMLYCD | |
| SCHEMBL5156043 | 0.83 | ALDH1A1 (0.49) | ALDH1A1MAPTL3MBTL1HPGDMLYCD | |
| SCHEMBL18864231 | 0.83 | MAPT (0.46) | ALDH1A1MAPTL3MBTL1HPGDMLYCD | |
| SCHEMBL6239726 | 0.83 | ALDH1A1 (0.46) | ALDH1A1MAPTL3MBTL1KDM4EKDM5A | |
| SCHEMBL3854935 | 0.83 | ALDH1A1 (0.77) | ALDH1A1MAPTL3MBTL1HPGDMLYCD | |
| SCHEMBL3853630 | 0.83 | HPGD (0.48) | ALDH1A1MAPTL3MBTL1HPGDMLYCD | |
| SCHEMBL6985934 | 0.80 | MAPT (0.43) | ALDH1A1MAPTL3MBTL1HPGDKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11045407-B2 | Process for treating keratin fibres with a pyridinedicarboxylic acid compound | L'OREAL (FR) | 2021-06-29 | — | — | US | disclosed |
| US-10857087-B2 | Process for treating keratin fibres with a polysaccharide and a pyridinedi-carboxylic acid compound | L'OREAL (FR) | 2020-12-08 | — | — | US | disclosed |
| EP-3110394-A1 | PROCESS FOR TREATING KERATIN FIBRES WITH A PYRIDINEDICARBOXYLIC ACID COMPOUND | L'Oréal (FR) | 2017-01-04 | — | — | EP | disclosed |
| EP-3107525-A1 | PROCESS FOR TREATING KERATIN FIBRES WITH A POLYSACCHARIDE AND A PYRIDINEDI-CARBOXYLIC ACID COMPOUND | L'Oréal (FR) | 2016-12-28 | — | — | EP | disclosed |
| US-20160228346-A1 | PROCESS FOR TREATING KERATIN FIBRES WITH A POLYSACCHARIDE AND A PYRIDINEDI-CARBOXYLIC ACID COMPOUND | L'OREAL (FR) | 2016-08-11 | — | — | US | disclosed |
| US-20160213587-A1 | PROCESS FOR TREATING KERATIN FIBRES WITH A PYRIDINEDICARBOXYLIC ACID COMPOUND | L'OREAL (FR) | 2016-07-28 | — | — | US | disclosed |
| WO-2015036477-A1 | PROCESS FOR TREATING KERATIN FIBRES WITH A PYRIDINEDICARBOXYLIC ACID COMPOUND | L'OREAL (FR) | 2015-03-19 | — | — | WO | disclosed |
| WO-2015036476-A1 | PROCESS FOR TREATING KERATIN FIBRES WITH A POLYSACCHARIDE AND A PYRIDINEDI-CARBOXYLIC ACID COMPOUND | L'OREAL (FR) | 2015-03-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11045407-B2 | Process for treating keratin fibres with a pyridinedicarboxylic acid compound | KRT18, CUTA, HKDC1 | ALDH1A1 1282/4885MAPT 361/4885L3MBTL1 4850/4885 |
| US-20160228346-A1 | PROCESS FOR TREATING KERATIN FIBRES WITH A POLYSACCHARIDE AND A PYRIDINEDI-CARBOXYLIC ACID COMPOUND | KRT18, HKDC1, PHYKPL | ALDH1A1 463/4885MAPT 900/4885L3MBTL1 4883/4885 |
| US-20160213587-A1 | PROCESS FOR TREATING KERATIN FIBRES WITH A PYRIDINEDICARBOXYLIC ACID COMPOUND | KRT18, CUTA, HKDC1 | ALDH1A1 1282/4885MAPT 361/4885L3MBTL1 4850/4885 |
| US-10857087-B2 | Process for treating keratin fibres with a polysaccharide and a pyridinedi-carboxylic acid compound | KRT18, HKDC1, PHYKPL | ALDH1A1 463/4885MAPT 900/4885L3MBTL1 4883/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.